EPISODE · Dec 14, 2018 · 24 MIN
Elixinol Global Limited (OTC: ELLXF) Fast growing revenues in CBD & Hemp consumer products
from Wall Street Reporter
We caught up with Paul, at the airport, to discuss Elixinol’s progress in the CBD and hemp consumer products and foods markets, which has resulted in over AUD$14 million revenues and profits in Q2 2018.Paul also talks about the company’s business strategy, and the plans for deploying a recent AUD$40 million capital raise, to expand global sales growth. Hosted on Acast. See acast.com/privacy for more information.
Embed this episode
NOW PLAYING
Elixinol Global Limited (OTC: ELLXF) Fast growing revenues in CBD & Hemp consumer products
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.